IBD Ulcerative Colitis Crohn’s Disease. IBD  Pathogenesis – genetics +environment (smoking,infection,drugs)  UC –bloody diarrhoea. Exacerbation & remission-50%/yr.

Slides:

Advertisements

Similar presentations

Inflammatory Bowel Disease: Overview

Advertisements

Is there a link between inflammatory bowel disease and the metabolic syndrome? Hester Franks Academic F2 Supervisors Professors Hawkey and Macdonald.

Immunomodulators and Biologics Maria T. Abreu, MD University of Miami Miller School of Medicine Miami, Florida.

GP Update on Inflammatory Bowel Disease

Colitis in the Very Young

Management of Inflammatory bowel disease 8/12/10.

Inflammatory Bowel Disease

Thiopurines still have a role in the management of pediatric IBD Athos Bousvaros MD, MPH Associate Director, IBD program Boston Children’s Hospital.

End points in IBD treatment Mucosal healing Vs Symptom relief Jose Francis Lakeshore Hospital Kochi.

Ghassan Wahbeh MD Associate Professor, Director IBD Program Seattle Children’s Hospital University of Washington.

CROHN’S DISEASE STJEPAN ĆURIĆ Mentor: A. Žmegač Horvat.

Inflammatory Bowel Disease

DRUG TREATMENT OF INFLAMMATORY BOWEL DISEASE. Objectives Describe the mechanism of action, pharmacokinetics and adverse effects of drugs in IBD.

Crohn’s disease - A Review of Symptoms and Treatment

Ulcerative Colitis. Which of the following would not be associated with UC Toxic megacolon Granulomas Pseudopolyps Primary sclerosing cholangitis.

UC. Ulcerative Colitis ( UC ) Ulcerative colitis is an inflammatory bowel disease (IBD) that causes chronic inflammation of the digestive tract It is.

Inflammatory Bowel Disease Treatment. Epidemiology Clinical Laboratory Imaging Pathology Response to treatment IBD.

Case A 25-year-old woman A 4-m history of abdominal pain in the left lower quadrant and bloody diarrhea.

(Date of presentation) (Name of presenter) UK IBD audit Biological therapies audit 2014 Comparison of (Your site name) results against the national results.

Case Presentation. Female Patient AB Aged 20 First seen by me in August 2009 Had been diagnosed with Crohn’s Disease in March 2009.

Dr. Angus Lee SET 1 General Surgery. Burrill Crohn, an American Gastroenterologist, with his 2 other colleagues first described “Terminal ileitis” in.

Date of presentation Name of presenter UK IBD Audit 3 rd Round Comparison of (Your Site Name) results against the National Results for Clinical Audit of.

Crohn’s Disease & Mycobacterial Infections Kimberly Persley, MD October 19, 2005.

Clinical Vignette: Medical Grand Rounds Joshua L. Denson MD Internal Medicine PGY2 January 7, 2013 U NITED S TATES D EPARTMENT OF V ETERANS A FFAIRS.

Page 1 United we Stand Supported by an educational grant from Abbott Detailed charts & tables.

Baumgart, D C The Diagnosis and Treatment of Crohn's Disease and Ulcerative Colitis Dtsch Arztebl Int 2009; 106(8): ; DOI: /arztebl

Beginning of the chapter Crohn's disease and genetics (IBD Sensor) 49.

Kim Eastman RN,MSN, CNS. INFLAMMATORY BOWEL DISEASE  OVERVIEW  IMMUNOLOGIC DISEASE THAT RESULTS IN INTESTINAL INFLAMMATION  ULCERATIVE COLITIS  CROHN’S.

Improving outcome of Inflammatory Bowel Disease in children Dinesh Pashankar, MD Pediatric Gastroenterologist Director- Pediatric IBD program Yale University.

What do these people all have in common?

Biological therapies audit 2016

Colorectal Cancer: Risk Prevention and Diagnosis

High and increasing prevalence of inflammatory bowel disease in Finland with a clear North–South difference Airi Jussila, Lauri J. Virta, Veikko Salomaa,

Work disability in inflammatory bowel disease

Ulcerative Colitis (UC)-Associated Colorectal Cancer (CRC) Patients Who Receives Colorectal Surgery More Likely Receive Blood Transfusion Than Crohn’s.

High and increasing prevalence of inflammatory bowel disease in Finland with a clear North–South difference Airi Jussila, Lauri J. Virta, Veikko Salomaa,

Medical management of inflammatory bowel disease

1 Patient enrollment flow chart.

Mersin University TURKEY

IBD vs IBS diagnosis and management

IBD Therapies: Guidance for Managed Care Professionals

Inflammatory Bowel Disease

Goals of Therapy for Patients With UC

Changing the IBD Paradigm

מחלות מעי דלקתיות והטיפול בהן

Complicated Cases in Ulcerative Colitis

Managing IBD in Children

Pathways in Managing Ulcerative Colitis

Volume 135, Issue 4, Pages (October 2008)

Volume 136, Issue 2, Pages (February 2009)

Patient Case: KC. Optimizing Treatment of Mild to Moderate Ulcerative Colitis: A Case-Based Perspective.

Volume 147, Issue 4, Pages e7 (October 2014)

Research and Healthcare in Inflammatory Bowel Diseases (1)

Figure 1 Environmental factors contributing to IBD pathogenesis

Volume 137, Issue 2, Pages (August 2009)

Itcoinitcoin ASAS. 4 I4 I,

Figure 1 Approximate timeline contrasting major historical events in the understanding of ulcerative colitis (red) and ... Figure 1 Approximate timeline.

Eligibility criteria for inclusion as an expert Delphi panellist

Translating Inflammatory Bowel Disease Research into Clinical Medicine

Rectal Mucosal Nitric Oxide in Differentiation of Inflammatory Bowel Disease and Irritable Bowel Syndrome Claudia I. Reinders, Max Herulf, Tryggve Ljung,

Meenakshi Bewtra, Chinyu Su, James D. Lewis

Crohn’s Disease Biologic Pathway

Comparative Studies of Biologics in Ulcerative Colitis

Risk factors for postoperative infection after lower gastrointestinal surgery in patients with inflammatory bowel disease: Findings from a large epidemiological.

Cox regression analysis of the proportion of patients remaining in remission during azathioprine treatment related to diagnosis of inflammatory bowel disease.

Cox regression analysis of the proportion of patients remaining in remission after stopping azathioprine treatment related to diagnosis of inflammatory.

You Don't Know JAK in IBD.

Presentation transcript:

IBD Ulcerative Colitis Crohn’s Disease

IBD  Pathogenesis – genetics +environment (smoking,infection,drugs)  UC –bloody diarrhoea. Exacerbation & remission-50%/yr  CD- more heterogenous – abdo pain,diarrhoea,wt loss,malaise,fever. 80% require surgery

Diagnosis  Colonoscopy – unless presenting with severe disease.  Terminal ileoscopy + BaFT  CT/MR/US/WBC scanning

Management  5ASAs + steroids – local/systemic  Azathioprine- good. TPMT assay  UC – consider CyA/infliximab  CD – Mtx/infliximab  The future – newer biological therapies